Material Insights · Understanding the Material World

CRISPR gene editing

A guide RNA leads a Cas enzyme to cut DNA at a chosen spot, so genes can be changed precisely.

Health and medicine · Biotechnology · No. 200

  • Networked and AI age
  • Readiness 9 of 9
  • Process
Health and medicine · Technology

A defence that bacteria use against viruses became, within eleven years, a licensed medicine aimed at curing an inherited blood disease.

Chart: Illustration: CRISPR gene editing

Where it comes from

Chart: Map of where it comes from

Biologists found odd repeats in bacterial DNA, named CRISPR in 2002. By 2007 they knew it was an immune system; in 2012 Charpentier and Doudna turned its cutting enzyme into a programmable tool.

Three things to know
  1. CRISPR is a bacterial immune system: in 2007 experiments showed that it protects bacteria against viruses.
  2. Casgevy, licensed in 2023, edits a patient's own blood stem cells so the body makes working haemoglobin.
  3. In 2021 WHO set out how to govern human genome editing, including registries of research and a way to report concerns in confidence.
The journey
  1. 1 BacteriaMicrobes store snippets of virus DNA to recognise repeat attacks
  2. 2 DiscoveryScientists work out how the stored snippets guide a cutting enzyme
  3. 3 ToolIn 2012 the enzyme is shown to cut any DNA a guide RNA points to
  4. 4 LaboratoryFrom 2013 it edits genes in human and mouse cells
  5. 5 ProductsEdited crops and, from 2023, a licensed medicine for blood disorders
Go deeper pick a tab to open it in full